947 Series B Startups to Watch in Europe
How do we build this list?
Tracking:
Last update to the database: April 9, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
Sign up to Seedtable Intel to access the entire database
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Disease prevention testing platform. |
$44M · Series B | F-Prime Capital, Lansdowne Partners, Foresite Capital | 51 to 100 | Health Tech | Oxford, UK | •••••••••••@genomicsplc.com | ||
Financial super app for waged workers. |
$21M · Series B | Village Global, Balderton Capital, Northzone | 101 to 250 | Fintech, Mobile, Payments | B2B, B2C, SaaS | London, UK | •••••••••••@wagestream.com | |
Payment software provider for SMBs. |
$3M · Seed | Dawn Capital, Seed Capital | 101 to 250 | Fintech, Payments | B2B, SaaS | Copenhagen, Denmark | •••••••••••@flatpay.com | |
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. |
$3M · Seed | Epidarex Capital, M Ventures, Oxford Science Enterprises | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Oxford, UK | •••••••••••@theolytics.com | |
Mosa Meat is a food technology company that produces a slaughter-free hamburger made directly from cow cells. |
$8M · Series A | Lowercarbon Capital, Target Global, InvestEU | 51 to 100 | Agritech, Foodtech, Manufacturing | B2B | Maastricht, Netherlands | •••••••••••@mosameat.com | |
Pre-employment screening platform. |
$128k · Seed | Atomico, SFC Capital, Stage 2 Capital | 51 to 100 | Hiring and Recruitement | B2B, SaaS | London, UK | •••••••••••@veremark.com | |
Mobile-first, open source neobank. |
$31M · Series B | Pollen Street Capital | 201 to 500 | Fintech, Payments | B2C, SaaS | Amsterdam, Netherlands | •••••••••••@bunq.com | |
AR platform for the automative industry. |
$23M · Series B | EIC Accelerator, Tesi, ETF Partners | 51 to 100 | AR / VR, Mobility & Transportation | B2B, SaaS | Helsinki, Finland | •••••••••••@basemark.com | |
Identity provider for digital advertising. |
$1M · Seed | 360 Capital, Progress Ventures, TransUnion | 11 to 50 | Adtech, Identity Management | B2B, SaaS | London, UK | •••••••••••@id5.io | |
Developer of full-spectrum microbial therapeutics. |
$630k · Seed | Scottish Investment Bank, Scottish National Investment Bank, Equity Gap | 11 to 50 | Health Tech, Biotech | Edinburgh, Scotland | •••••••••••@enterobiotix.com | ||
Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC). |
$940k · Seed | Octopus Ventures, Longwall Venture, BlueYard Capital | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@biofidelity.com | |
CryoTherapeutics is focusing on the development, demonstration of clinical benefit & commercialization of a proprietary cryotherapy system. |
$10M · Series B | Meusinvest (Noshaq), Yellowstone Holding, Peppermint Venture Partners | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Potsdam, Germany | •••••••••••@cryotherapeutics.com | |
Generative AI platform for law firms. |
$3M · Seed | Talis Capital, National Grid Partners (NGP), March Capital | 101 to 250 | AI, Legal Tech | B2B, SaaS | Cambridge, UK | •••••••••••@luminance.com | |
Sustainable packaging solutions developer. |
$12M · Series B | Circular Innovation Fund, European Circular Bioeconomy Fund (ECBF) | 101 to 250 | Climate Tech & Green Tech | B2B | Dresden, Germany | •••••••••••@watttron.com | |
AAA games developers. |
$20M · Series B | Shima Capital | 101 to 250 | Gaming, Video | B2C, SaaS | Frankfurt, Germany | •••••••••••@gunzillagames.com | |
Heart surgery device maker. |
$10M · Series A | Segulah Medical Acceleration, TechVision Fonds, Coparion | 1 to 10 | Health Tech, Manufacturing | B2B | Aachen, Germany | •••••••••••@protembis.com | |
Blood purification platform. |
$15M · Series B | Hemex, Belmondo, VP Venture Partners | 11 to 50 | Health Tech | B2B | Zürich, Switzerland | •••••••••••@hemotune.ch | |
New drug application (NDA) IB1001 developer for the treatment of Niemann-pick disease type C (NPC). |
$10M · Series A | 1 to 10 | Health Tech, Biotech | Oxford, UK | •••••••••••@intrabio.com | |||
Carbon accounting platform. |
$52M · Series B | Fidelity International Strategic Ventures, Benhamou Global Ventures, Move Capital | 101 to 250 | Climate Tech & Green Tech | B2B, SaaS | Paris, France | •••••••••••@greenly.earth | |
NX Technologies provides digital and automated payment management and solutions. |
$23M · Series B | Motive Partners, PayPal Ventures, Seaya Ventures | 101 to 250 | Fintech | Cologne, Germany | •••••••••••@bezahl.de | ||
Medical devices developer for spine specialist surgeons. |
$32M · Series B | Gimv, Ernst Gohner Stiftung | 101to 250 | Health Tech, Hardware | B2B | Geneva, Switzerland | •••••••••••@spineart.com | |
Provider of insurance solutions in Europe. |
$11M · Series A | MS&AD Ventures, finleap, Mundi Ventures | 101 to 250 | Insuretech | B2B, SaaS | Berlin, Germany | •••••••••••@element.in | |
Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases. |
$139M · Series B | Nextech Invest, EQT Life Sciences, Andera Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Munich, Germany | •••••••••••@tubulis.com | |
Journey management platform. |
$460k · Pre Seed | Blossom Capital, 20SALES, 20VC | 11 to 50 | Productivity Tools | B2C, SaaS | Amsterdam, Netherlands | •••••••••••@theydo.com | |
Deubiquitylating enzyme (DUB) drug discovery and development platform. |
$6M · Series A | Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments | 51 to 100 | Health Tech, Biotech | Cambridge, UK | •••••••••••@missiontherapeutics.com | ||
E-bike mobility platform. |
$2M · Seed | Balderton Capital, Local Globe, Creandum | 1001 to 5000 | B2C | Stockholm, Sweden | •••••••••••@voi.com | ||
Cyber threat protection platform for businesses. |
$39M · Series B | Bessemer Venture Partners, JP Morgan, TIIN Capital | 51 to 100 | Cybersecurity | B2B, SaaS | The Hague, Netherlands | •••••••••••@eye.security | |
Solar energy producer. |
$200M · Series B | BlackRock, Redalpine | 51 to 100 | Climate Tech & Green Tech, Energy & Nuclear | B2C | Frankfurt, Germany | •••••••••••@enviria.energy | |
Aviation propulsion system developer. |
$21M · Series B | Breeze Invest | 11 to 50 | Space Tech | B2B | Linz, Austria | •••••••••••@cyclotech.at | |
AI-powered image editing platform. |
$43M · Series B | Balderton Capital, Kima Ventures, Aglaé Ventures | 1 to 10 | AI, Art | SaaS, B2C | Paris, France | •••••••••••@photoroom.com | |
Cardiac ablation system developer for treating cardiac arrhythmias. |
$58M · Series B | Advent Life Sciences, Gilde Healthcare, Earlybird Venture Capital | 1 to 10 | Health Tech | Lausanne, Switzerland | •••••••••••@argamedtech.com | ||
Connected robotics automation solutions for SMEs. |
$3M · Pre Seed | Sequoia Capital, Kindred Capital, Lightspeed Venture Partners | 51 to 1000 | Robotics, Manufacturing | B2B | Munich, Germany | •••••••••••@rob.co | |
Digital lending platform. |
$10M · Series A | 101 to 250 | Fintech, Payments | B2C, SaaS | Lausanne, Switzerland | •••••••••••@zoodpay.com | ||
SME banking platform. |
$53M · Series B | General Catalyst, Northzone, Target Global | 101 to 250 | Fintech, Payments | B2B, SaaS | Amsterdam, Netherlands | •••••••••••@finom.co | |
Short-stay apartment rental marketplace. |
$4M · Seed | Flashpoint, Tesi, Superangel | 11 to 50 | Proptech & Real Estate | B2C, Marketplace | Helsinki, Finland | •••••••••••@bobw.co | |
Smartphone imaging technology. |
$1M · Seed | Supernova Invest, Atlantic Bridge, Intel Capital | 101 to 250 | Hardware, Manufacturing | B2B | Cambridge, UK | •••••••••••@cambridgemechatronics.com | |
Asset management platform. |
$40M · Series B | Expedition Growth Capital | 11 to 50 | Fintech | B2B, SaaS | Stockholm, Sweden | •••••••••••@xensam.com | |
Cannabis-based medicines developer. |
$21M · Series B | 51 to 200 | Health Tech, Biotech | Frankfurt, Germany | •••••••••••@avextra.com | |||
SaaS-based workflow automation platform. |
$26M · Series B | Federated Hermes, Kennet Partners | 51 to 100 | Sales and Marketing | B2B, SaaS | London, UK | •••••••••••@screendragon.com | |
Plant-based meat producer. |
$42M · Series B | Newtree Impact, Upfield, Unovis Asset Management | 101 to 250 | Foodtech, Manufacturing | B2C | Barcelona, Spain | •••••••••••@heurafoods.com | |
Cloud-native banking platform for businesses. |
$26M · Series B | Speedinvest, CommerzVentures, Plug and Play Spain | 51 to 100 | Fintech, Payments | B2B, SaaS | Tallinn, Estonia | •••••••••••@tuumplatform.com | |
Intelligent automation platform for audit and finance professionals. |
$100M · Series B | Index Ventures | 11 to 50 | Fintech, AI | B2B, SaaS | Amsterdam, Netherlands | •••••••••••@datasnipper.com | |
Hybrid-electric airplane maker. |
$107M · Series B | Lowercarbon Capital, Sagitta Ventures, EQT Ventures | 101 to 250 | Space Tech, Mobility & Transportation | B2B | Gothenburg, Sweden | •••••••••••@heartaerospace.com | |
Small molecule neoantigen immuno-oncology therapies developer. |
$12M · Series B | Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management | 1 to 10 | Health Tech | Cambridge, UK | •••••••••••@neophore.com | ||
Energy transition and decarbonization technology for transport industry. |
$11M · Series B | Santander Asset Management, Solvay Ventures, Tech4Planet | 51 to 100 | Climate Tech & Green Tech, Mobility & Transportation | B2B | Turin, Italy | •••••••••••@tau.group | |
Developer of drugs to treat respiratory diseases. |
$2M · Series A | Versant Ventures, Forbion Capital Partners, Imperial Innovations | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@enterprisetherapeutics.com | ||
Graphic design platform. |
$1M · Seed | IVP, Left Lane Capital, Speedinvest | 11 to 50 | Art | B2C, SaaS | Berlin, Germany | •••••••••••@kittl.com | |
EV charging platform. |
$87M · Series B | Quantum Light, GreenPoint Partners, Creandum | 101 to 250 | Mobility & Transportation, Energy & Nuclear | B2B | Copenhagen, Denmark | •••••••••••@monta.com | |
Door-to-door transfer platform. |
$700k · Seed | Euroventures, J&T Ventures, Taiwania Capital | 11 to 50 | Travel Tech | B2C, SaaS | London, UK | •••••••••••@mydaytrip.com | |
Small launch vehicle maker for space. |
$810k · Pre Seed | Bpifrance, Kima Ventures, Crédit Mutuel Innovation | 51 to 100 | Space Tech, Mobility & Transportation | B2B | Paris, France | •••••••••••@latitude.eu | |
Scientific research platform. |
$1M · Seed | Molten Ventures, Cherry Ventures, Emerge Education | 101 to 250 | Future of Work | B2B, SaaS | Berlin, Germany | •••••••••••@morressier.com | |
Grayscale bitcoin ETF liquidity provider. |
$50M · Series B | Eurazeo, Cathay Innovation, Fabric Ventures | 51 to 100 | Fintech, Crypto & web3 | B2B | Paris, France | •••••••••••@flowdesk.co | |
Product traceability and compliance platform. |
$24M · Series B | Circularity Capital, Industrifonden, Fairpoint Capital | 11 to 50 | Supply Chain & Logistics | B2B, SaaS | Stockholm, Sweden | •••••••••••@trustrace.com | |
Personalised therapeutic vaccine developer for colorectal cancer. |
$8M · Series B | 1 to 10 | Health Tech, Biotech | B2C | Grenoble, France | •••••••••••@pdc-line-pharma.com | ||
Spend management SaaS platform. |
$25M · Series B | 83North, Bessemer Venture Partners | 101 to 250 | Fintech | B2B, SaaS | London, UK | •••••••••••@vertice.one | |
AI-powered communication platform for sales team. |
$28M · Series B | Point Nine Capital, henQ, KPN Ventures | 101 to 250 | AI, Communications | B2B, SaaS | Bratislava, Slovakia | •••••••••••@cloudtalk.io | |
Clean energy-tech provider. |
$95M · Series A | Altor, Temasek Holdings, Creades AB | 250 to 500 | Climate Tech & Green Tech | B2B | Stockholm, Sweden | •••••••••••@airahome.com | |
Producer of e-fuels. |
$128M · Series B | Piva Capital, MPC Capital, Extantia Capital | 101 to 250 | Climate Tech & Green Tech, Energy & Nuclear | B2B | Karlsruhe, Germany | •••••••••••@ineratec.de | |
Precision medicine developer for neuropsychiatric and neurological disorders. |
$13M · Series B | SPRIM Global Investments | 11 to 50 | Biotech | Geneva, Switzerland | •••••••••••@stalicla.com | ||
On-street electric vehicle charging technology. |
$1M · Seed | Alba Equity, Business Growth Fund, Scottish Investment Bank | 11 to 50 | Mobility & Transportation, Energy & Nuclear | B2C | Edinburgh, Scotland | •••••••••••@trojanenergyltd.com | |
Fast-charging network for electric vehicles. |
$332M · Series B | Rive Private Investment, PGGM, Bpifrance | 101 to 250 | Mobility & Transportation, Energy & Nuclear | B2C | Paris, France | •••••••••••@go-electra.com | |
Solar energy producer. |
$32M · Series B | Shell Ventures, Fifth Wall, ArcTern Ventures | 101 to 250 | Climate Tech & Green Tech, Energy & Nuclear | B2C | Groningen, The Netherlands | •••••••••••@soly-energy.com | |
Digital insurance platform. |
$73M · Series B | A16Z, Battery Ventures, Highland Europe | 1 to 10 | Insuretech | B2C, Marketplace | London, UK | •••••••••••@hyperexponential.com | |
Humanoid robots maker for consumer use. |
$100M · Series B | OpenAI Startup Fund, Skagerak Capital, Valinor AS | 51 to 100 | Deep Tech, Robotics | B2C | Oslo, Norway | •••••••••••@1x.tech | |
High speed data converter chips manufacturer. |
$37M · Series B | NCI Waterstart, Bpifrance, BNP Paribas | 51 to 100 | Manufacturing, Semiconductor | B2B | Paris, France | •••••••••••@scalinx.com | |
Battery energy storage systems (BESS). |
$28M · Series B | OP Financial Group, Finnish Climate Fund, Superhero Capital | 1 to 10 | Climate Tech & Green Tech, Energy & Nuclear | Helsinki, Finland | •••••••••••@cactos.fi | ||
Crypto custody and staking service provider. |
$15M · Series B | Balderton Capital, Maven 11 Capital, Coparion | 51 to 100 | Crypto & web3 | B2B | Berlin, Germany | •••••••••••@finoa.io | |
AI-powered multilingual content generation platform. |
$18M · Series B | Synergo Capital, Tech4Planet | 51 to 100 | AI, Sales and Marketing | B2B, SaaS | Milan, Italy | •••••••••••@contents.com | |
Medicine for rare neurological diseases. |
$59M · Series B | Idinvest Partners, EQT Life Sciences, Droia Ventures | 11 to 50 | Biotech, Pharma | B2C | The Hague, Netherlands | •••••••••••@vicotx.com |
Sign up to access our full database
Enter your email and get access to 17k+ technology companies you can partner with